Greenland
Diabetes country report 2024 — 2050
Skip Map
Number of adults (20–79 years) with diabetes in Greenland (GL)
| 2024 | 2.0 thousand |
| 2050 | 2.1 thousand |
Greenland is one of the 60 countries and territories in the IDF Europe Region.
Data source(s) used for the diabetes estimates in adults:
- Backe MB, Pedersen ML Diabetes Res Clin Pract. 2020 Feb;160:107991. doi: 10.1016/j.diabres.2019.107991. Epub 2019 Dec 23. PMID:31877343
2000
2011
2024
2050
Loading...
| Diabetes estimates (20-79 y) | ||||
|---|---|---|---|---|
| People with diabetes, in 1,000s | - | - | 2.0 | 2.1 |
| Age-standardised prevalence of diabetes, % | - | - | 4.3 | 5.2 |
| Proportion of people with undiagnosed diabetes, % | - | - | 28.5 | - |
| People with undiagnosed diabetes, in 1,000s | - | - | 0.6 | - |
| Impaired Fasting Glucose (IFG) | ||||
|---|---|---|---|---|
| People with IFG, in 1,000s | - | - | 2.3 | 2.1 |
| Age-standardised prevalence of IFG, % | - | - | 5.1 | 5.2 |
| Impaired Glucose Tolerance (IGT) | ||||
|---|---|---|---|---|
| People with IGT, in 1,000s | - | - | 3.6 | 3.8 |
| Age-standardised prevalence of IGT, % | - | - | 8.0 | 9.4 |
| Mortality attributable to diabetes (20-79 y) | ||||
|---|---|---|---|---|
| Deaths attributable to diabetes | - | - | 40.6 | - |
| Proportion of diabetes-related deaths in people 20-79 y, % | - | - | 9.4 | - |
| Hyperglycaemia in pregnancy (HIP) (20-49 y) | ||||
|---|---|---|---|---|
| Live births affected by HIP | - | - | - | - |
| Prevalence of gestational diabetes mellitus (GDM), % | - | - | - | - |
| Live births affected by other types of diabetes first detected in pregnancy | - | - | - | - |
| Live births affected by other types of diabetes detected prior to pregnancy | - | - | - | - |
| Diabetes-related health expenditure | ||||
|---|---|---|---|---|
| Total diabetes-related health expenditure, USD million | - | - | - | - |
| Total diabetes-related health expenditure, ID million | - | - | - | - |
| Diabetes-related health expenditure per person, USD | - | - | - | - |
| Diabetes-related health expenditure per person, ID | - | - | - | - |
| Type 1 diabetes estimates in children and adolescents | ||||
|---|---|---|---|---|
| People with type 1 diabetes (all age groups) | - | - | - | - |
| People with type 1 diabetes (0-19 y) | - | - | - | - |
| Demographics | ||||
|---|---|---|---|---|
| Total adult population (20-79 y), in 1,000s | - | - | 40.5 | 38.1 |
| Population of children and adolescents (0-19 y) | - | - | - | - |
Loading...
| Diabetes estimates (20-79 y) | |
|---|---|
| People with diabetes, in 1,000s | - |
| Age-standardised prevalence of diabetes, % | - |
| Proportion of people with undiagnosed diabetes, % | - |
| People with undiagnosed diabetes, in 1,000s | - |
| Impaired Fasting Glucose (IFG) | |
|---|---|
| People with IFG, in 1,000s | - |
| Age-standardised prevalence of IFG, % | - |
| Impaired Glucose Tolerance (IGT) | |
|---|---|
| People with IGT, in 1,000s | - |
| Age-standardised prevalence of IGT, % | - |
| Mortality attributable to diabetes (20-79 y) | |
|---|---|
| Deaths attributable to diabetes | - |
| Proportion of diabetes-related deaths in people 20-79 y, % | - |
| Hyperglycaemia in pregnancy (HIP) (20-49 y) | |
|---|---|
| Live births affected by HIP | - |
| Prevalence of gestational diabetes mellitus (GDM), % | - |
| Live births affected by other types of diabetes first detected in pregnancy | - |
| Live births affected by other types of diabetes detected prior to pregnancy | - |
| Diabetes-related health expenditure | |
|---|---|
| Total diabetes-related health expenditure, USD million | - |
| Total diabetes-related health expenditure, ID million | - |
| Diabetes-related health expenditure per person, USD | - |
| Diabetes-related health expenditure per person, ID | - |
| Type 1 diabetes estimates in children and adolescents | |
|---|---|
| People with type 1 diabetes (all age groups) | - |
| People with type 1 diabetes (0-19 y) | - |
| Demographics | |
|---|---|
| Total adult population (20-79 y), in 1,000s | - |
| Population of children and adolescents (0-19 y) | - |
